Exozymes (EXOZ) Daily Trading Snapshot – 21 Oct 2026
Trading Performance (24 h ending 09:00 AM CET)
- Exozymes shares fell by 2.2 %.
- Current trading price: USD 4.12.
- Daily volume: USD 35,200.
Company Metrics
- Shares outstanding: 9.3 million.
- Market capitalization: USD 38 million.
- 200‑day simple moving average: USD 8.04.
Historical Price Range
- 52‑week high: USD 18.40 (10 Nov 2025).
- 52‑week low: USD 3.70 (15 Oct 2026).
Month‑End Trend
- Since the end of last month, Exozymes shares have declined 34.85 %.
Comparative Performance of Related Stocks (Last 24 h)
| Ticker | Recent Change | Current Price (USD) | Market Cap (USD) | PE Ratio |
|---|---|---|---|---|
| KLRS (Kalaris Therapeutics) | –4.5 % | 2.07 | 44.8 mn | – |
| QETA (Quetta Acquisition) | +3.8 % | 12.35 | 44.4 mn | 49.31 |
| CATO (Cato) | –1.7 % | 2.31 | 44.6 mn | – |
| HGBL (Heritage Global) | –1.54 % | 1.27 | 45.0 mn | – |
| SDEV (Stablecoin Development) | –4.55 % | 0.83 | 44.6 mn | 0.18 |
Key Takeaways
- Exozymes’ share price remains below its 200‑day average and is approaching its 52‑week low.
- The month‑to‑date decline of 34.85 % indicates a significant downtrend relative to the broader sector.
- Among peer companies, only Quetta Acquisition showed positive momentum in the last 24 hours, driven by a strong price‑to‑earnings ratio.
- The sector exhibits a mix of high‑growth and value‑focused profiles, with varying P/E valuations that may influence future trading dynamics.
